by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials
The planned innovative Phase 2 study of RHB-2041 will be the first ever clinical study in Crohn’s Disease (CD) patients who are all MAP-positive, and will… The planned innovative Phase 2 study of RHB-2041 will be the first ever clinical study in...
